Acquisition (code M) of 6,250 shares at $0 per share.
Reporting Person Adams Kendra · Officer Title Chief Financial Officer · Transaction Code M
Traded Sep 18, 2026 · Disclosed Sep 21, 2026
Source: SEC Form 4 · 0001470831-26-000895 · filed 2026-09-21 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "C4 Therapeutics, Inc. (CCCC)." Disclosed 2026-09-21. https://desqlong.com/cards/0001470831-26-000895-1 (retrieved 2026-09-26).